KKR Genetic Disorder GP LLC
- SEC CIK
- 0001780428
No open-market purchases or sales filed in the past year.
Current role at each company
- BBIO BridgeBio Pharma, Inc.10% Owneras of May 14, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists KKR Genetic Disorder GP LLC as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 (view filing)5:24 PM ET | May 12 | 2 days | Kravis Henry R and 8 others10% Owner | SSale | −6.00M | $34.20 | −$205.2M | −31.2%13.3M after | |
| Mar 7, 2025 (view filing)6:09 PM ET | Mar 5 | 2 days | Kravis Henry R and 8 others10% Owner | SSale | −6.00M | $32.96 | −$197.8M | −23.8%19.3M after | |
| Sep 17, 2024 (view filing)6:44 PM ET | Sep 13 | 4 days | Kravis Henry R and 8 others10% Owner | SSale | −5.80M | $25.75 | −$149.3M | −18.7%25.3M after |